PA
XRN

PharVision Advisers’s Chiron Real Estate Inc XRN Stock Holding History

PharVision Advisers’s Portfolio XRN Stock Details XRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-4,184
Closed -$161K – 368
2024
Q4 		$161K Buy
+4,184
New +$185K 0.14% 340

Other funds holding XRN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Prudential Financial
Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Mirae Asset Global ETFs Holdings
Mirae Asset Global ETFs Holdings Causeway Bay, Hong Kong $73.7B AUM 53.56% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

PharVision Advisers's XRN Position: Q1 2025 in Review

PharVision Advisers sold out of Chiron Real Estate Inc (XRN) in Q1 2025, closing a stake of 4,184 shares — an estimated $161K sold.

PharVision Advisers first reported a position in XRN in Q4 2024 and held it in 1 quarter. The position peaked at $161K in Q4 2024. 204 funds tracked by Wall St. Rank hold XRN as of Q1 2025.

  • PharVision Advisers reported no remaining Chiron Real Estate Inc position as of Q1 2025 after selling out during the quarter.
  • PharVision Advisers sold 4,184 Chiron Real Estate Inc shares in Q1 2025, an estimated $161K.
  • PharVision Advisers first reported a position in Chiron Real Estate Inc in Q4 2024 and held it in 1 quarter.
  • PharVision Advisers's Chiron Real Estate Inc position peaked at $161K in Q4 2024.
  • 204 funds tracked by Wall St. Rank held Chiron Real Estate Inc as of Q1 2025.

Based on PharVision Advisers's 13F filing for Q1 2025, filed 15 May 2025.